
Spain’s competition watchdog CNMC said on Wednesday it was investigating possible anti-competitive practices in the marketing of state-backed loans by lenders Banco Sabadell, Santander, Caixabank and Bankia.
The CNMC said it had opened disciplinary proceedings against the banks over alleged irregularities involving state-backed credit lines to help companies and households cope with the impact of COVID-19.
This now opens a maximum period of 18 months for the investigation and resolution of the case by the CNMC.
The Spanish government approved last year up to 100 billion euros ($121.3 billion) in so-called ICO liquidity lines, where the state guaranteed up to 80% of the loans. They were channelled through banks mainly to small and mid-sized companies and the self-employed.
The CNMC said it was investigating whether banks had required customers to buy financial products as a precondition to receive these loans.
Sabadell and Caixabank, which as of end March legally closed the acquisition of Bankia, declined to comment.
Santander said it had complied with regulations governing the ICO loans and that it had not made ICO-guaranteed financing contingent on any product or service. It said it was awaiting further information on the details of the investigation.
The CNMC said it was also analysing whether loans were used to restructure pre-existing financial debts, it said.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Athletes File New Objections to NCAA’s $2.8 Billion Settlement Proposal
May 15, 2025 by
CPI
TikTok Charged by EU Over Alleged Breach of Digital Services Act
May 15, 2025 by
CPI
House Budget Bill’s Moratorium on State AI Laws Could Undo A Range of Tech Regs, Critics Say
May 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas